DB
RYTM icon

Danske Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Danske Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Hold
100
– – ﹤0.01% 806
2026
Q1 		$8.7K Sell
100
-1,000
-91% -$97.2K ﹤0.01% 826
2025
Q4 		$118K Buy
+1,100
New +$117K ﹤0.01% 749

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Danske Bank's RYTM Position: Q2 2026 in Review

Danske Bank held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 100 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Danske Bank first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $118K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Danske Bank held 100 shares of Rhythm Pharmaceuticals worth $11.1K as of Q2 2026.
  • Danske Bank left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #806 holding.
  • Danske Bank first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Danske Bank's Rhythm Pharmaceuticals position peaked at $118K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.